S- [2-[(1-Iminoethyl)amino]ethyl]-2-methylL-cysteine maleate hydrochloride crystalline salt

Details for Australian Patent Application No. 2004220266 (hide)

Owner Pharmacia Corporation

Inventors Brostrom, Lyle R.; Zia, Vahid; Czyzewski, Ann M.; Sheikh, Ahmad

Agent Shelston IP

Pub. Number AU-B-2004220266

PCT Pub. Number WO2004/080956

Priority 60/453,496 11.03.03 US

Filing date 4 March 2004

Wipo publication date 23 September 2004

Acceptance publication date 19 August 2010

International Classifications

C07C 323/59 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

A61K 31/198 (2006.01)

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07C 319/28 (2006.01) Preparation of thiols, sulfides, hydropolysulfides or polysulfides

C07C 323/39 (2006.01) Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups

Event Publications

1 September 2005 PCT application entered the National Phase

  PCT publication WO2004/080956 Priority application(s): WO2004/080956

19 August 2010 Application Accepted

  Published as AU-B-2004220266

16 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004220269-3-(1-(3-(1,3-benzothiazol-6-yl)propylcar bamoyl)cycloalkyl)propanoic acid derivatives as NEP inhibitors

2004220265-Production of linear alkyl benzene